» Articles » PMID: 12573434

RUNX Transcription Factors As Key Targets of TGF-beta Superfamily Signaling

Overview
Publisher Elsevier
Specialties Biology
Genetics
Date 2003 Feb 8
PMID 12573434
Citations 125
Authors
Affiliations
Soon will be listed here.
Abstract

The Runt domain transcription factors, RUNX1, RUNX2 and RUNX3, are integral components of signaling cascades mediated by both TGF-beta and bone morphogenetic proteins (BMPs) in several important biological systems. RUNX2 functions synergistically with Smad1 and Smad5 to regulate bone-specific genes when BMP induces osteogenesis. RUNX3, which has been mapped to locus 1p36, is a major tumor suppressor of gastric cancer and appears to be an important component of the TGF-beta-induced tumor suppressor pathway. A possible relationship between the TGF-beta-induced tumor-suppressor pathway and a postulated tumor suppressor gene on 1p36 must be examined.

Citing Articles

CD109, a master regulator of inflammatory responses.

Batal A, Garousi S, Finnson K, Philip A Front Immunol. 2025; 15:1505008.

PMID: 39990858 PMC: 11842317. DOI: 10.3389/fimmu.2024.1505008.


A polycomb group protein EED epigenetically regulates responses in lipopolysaccharide tolerized macrophages.

Boonmee A, Benjaskulluecha S, Kueanjinda P, Wongprom B, Pattarakankul T, Sri-Ngern-Ngam K Epigenetics Chromatin. 2024; 17(1):36.

PMID: 39614386 PMC: 11606203. DOI: 10.1186/s13072-024-00562-6.


mA/YTHDF2-mediated mRNA decay targets TGF-β signaling to suppress the quiescence acquisition of early postnatal mouse hippocampal NSCs.

Zhang F, Fu Y, Jimenez-Cyrus D, Zhao T, Shen Y, Sun Y Cell Stem Cell. 2024; 32(1):144-156.e8.

PMID: 39476834 PMC: 11698649. DOI: 10.1016/j.stem.2024.10.002.


Epigenetic memory of radiotherapy in dermal fibroblasts impairs wound repair capacity in cancer survivors.

Bian X, Piipponen M, Liu Z, Luo L, Geara J, Chen Y Nat Commun. 2024; 15(1):9286.

PMID: 39468077 PMC: 11519383. DOI: 10.1038/s41467-024-53295-1.


Predicting mechanism of immune response in microsatellite instability colorectal cancer.

Sun P, Luan Y, Cai X, Liu Q, Ren P, Xin P Heliyon. 2024; 10(6):e28120.

PMID: 38545192 PMC: 10965513. DOI: 10.1016/j.heliyon.2024.e28120.